Nothing Special   »   [go: up one dir, main page]

AU4664689A - Proteolytic fragments obtained from human cytomegalovirus glycoprotein complex i - Google Patents

Proteolytic fragments obtained from human cytomegalovirus glycoprotein complex i

Info

Publication number
AU4664689A
AU4664689A AU46646/89A AU4664689A AU4664689A AU 4664689 A AU4664689 A AU 4664689A AU 46646/89 A AU46646/89 A AU 46646/89A AU 4664689 A AU4664689 A AU 4664689A AU 4664689 A AU4664689 A AU 4664689A
Authority
AU
Australia
Prior art keywords
human cytomegalovirus
fragments obtained
proteolytic fragments
glycoprotein complex
cytomegalovirus glycoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46646/89A
Inventor
Richard C. Gehrz
Bruce E. Kari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Hospital Inc
Original Assignee
Childrens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hospital Inc filed Critical Childrens Hospital Inc
Publication of AU4664689A publication Critical patent/AU4664689A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16111Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
AU46646/89A 1988-12-12 1989-11-15 Proteolytic fragments obtained from human cytomegalovirus glycoprotein complex i Abandoned AU4664689A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28260688A 1988-12-12 1988-12-12
US282606 1988-12-12

Publications (1)

Publication Number Publication Date
AU4664689A true AU4664689A (en) 1990-07-10

Family

ID=23082259

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46646/89A Abandoned AU4664689A (en) 1988-12-12 1989-11-15 Proteolytic fragments obtained from human cytomegalovirus glycoprotein complex i

Country Status (4)

Country Link
AU (1) AU4664689A (en)
CA (1) CA2003943A1 (en)
IL (1) IL92447A0 (en)
WO (1) WO1990006771A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591439A (en) * 1989-03-24 1997-01-07 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
US5552143A (en) * 1989-03-24 1996-09-03 The Wistar Institute Of Anatomy & Biology Recombinant cytomegalovirus vaccine
CA2160583A1 (en) * 1993-04-16 1994-10-27 Stanley A. Plotkin Recombinant cytomegalovirus vaccine
WO1997040165A1 (en) 1996-04-23 1997-10-30 The Wistar Institute Of Anatomy And Biology Novel human cytomegalovirus dna constructs and uses therefor
NZ600974A (en) 2009-12-23 2014-08-29 4Antibody Ag Binding members for human cytomegalovirus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689225A (en) * 1984-11-02 1987-08-25 Institut Merieux Vaccine for cytomegalovirus

Also Published As

Publication number Publication date
WO1990006771A1 (en) 1990-06-28
IL92447A0 (en) 1990-08-31
CA2003943A1 (en) 1990-06-12

Similar Documents

Publication Publication Date Title
AU5181190A (en) Multifunctional facial tissue
AU3414689A (en) Therapeutic peptides
AU3604889A (en) Depilation apparatus
AU3977589A (en) Novel peptides
AU7412787A (en) Glycoprotein of human cytomegalovirus
AU3906289A (en) Novel expression system
AU1094588A (en) Novel preset necktie
AU3108389A (en) Polypeptides
AU3967889A (en) Immunogenic glycoproteins of human cytomegalovirus gcii
AU3631789A (en) Escape system
GB8729251D0 (en) Human cytomegalovirus protein
AU4664689A (en) Proteolytic fragments obtained from human cytomegalovirus glycoprotein complex i
AU3804589A (en) Novel proteins
AU4122689A (en) Human rhinovirus peptides
AU3549489A (en) Human gm-csf variants
AU3804689A (en) Modified proteins
GB2225237B (en) Ophthalmic preparations
AU3283789A (en) Immunogenic glycoproteins of human cytomegalovirus
AU6420690A (en) Walkway unit
AU5050490A (en) Human monocyte-macrophage-csf preparations
AU3849989A (en) Antibody recognition of fragments from cytomegalovirus
AU3048689A (en) Immunogenic peptides
AU2885689A (en) Novel proteins derived from human alpha2-plasmin inhibitor orproteins similar thereto
AU4603289A (en) Novel treatment
GB2273710B (en) Peptide fragments of HIV